Navigation Links
Inquiry Fixed Curve Diagnostic Catheters

ProductsInquiry Fixed Curve Diagnostic Catheters
Company Irvine Biomedical Inc.
Item Inquiry Fixed Curve Diagnostic Catheters
Features 
  • Precision handling designed to reduce procedure times - precise torqueability and pushability allow fast catheter placement and provide long-term tip stability
  • Consistent high fidelity diagnostic electrograms - platinum iridium electrodes, gold plated connectors and copper conductors produce high fidelity electrograms for easier interpretation
  • Rapid Connections - Quick Connect connector design provides a single-step cable connection for faster procedures
    • Description 4Fr, 5Fr & 6Fr diagnostic electrophysiology catheters with fixed curves.
    Info Irvine Biomedical Inc.
    Customer Service: (888) IBI-9876
    Web site: http://www.ibiep.com/

    Related medicine products :

    1. Inquiry Steerable Diagnostic Catheters
    2. Inquiry HIS Diagnostic Catheters
    3. Inquiry H Steerable Diagnostic Catheters
    4. Straight Fixed Core Wire Guides
    5. Small Anatomy Fixed Curve Catheters
    6. Webster Small Anatomy Fixed Curve Catheters
    7. Webster Supra CS Decapolar (Coronary Sinus Fixed Curve Catheters)
    8. Explorer ST Fixed Curve Diag. Catheters
    9. Webster Santoro 20 Pole Fixed Curve Catheter
    10. Luma-Cath Lumen Diagnostic Mapping Catheters Fixed and Steerable Curves
    11. Webster Luminal Decapolar (Coronary Sinus Fixed Curve Catheters)
    ...lace the eyeglasses in the EZ Meter and press the ...display the measurement results on its large color...a printout makes this the ideal instrument for use...tion to being extremely easy-to-use, the EZ-200 is...
    The Surgiflex WAVE XP couples the state-of-the-art Surgiflex WAVE Probe with the convenience of a truly portable battery-powered pump.
    Stryker Endoscopy has combined a standardized pressurizing system with an advanced hand piece design that is lightweight and compact in order to streamline laparoscopic procedures.
    Developed specifically to disintegrate renal and ureteral stones, the LithoDiamond features state-of-the-art technology in a compact design to deliver an exceptionally efficient and affordable lithot
    Medicine Products:
    (Date:9/5/2008)...Expert Pathologists Discuss the Latest Development... NORTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/...on point. Molecular testing and the promise,of per...e treated. Digital,slides and other imaging techno...College of American Pathologists is taking a leade...
    (Date:9/5/2008)...tional Survey From American Humane Shows Public Re...ricane Gustav Pet Evacuation Efforts Confirm ...pt. 5 /PRNewswire/ -- A 2007 survey by the America...icans would refuse rescue,assistance if it meant l...anna, Ike and Josephine moving towards the U.S. co...
    (Date:9/5/2008)...Advocates call on John McCain to commit to develop...IS and ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewsw...ed last night with no mention of the,domestic AIDS...ference to,the epidemic overseas. Neither Presiden...l nominee Gov. Sarah Palin mentioned AIDS in their...
    (Date:9/5/2008)...The National Institute of Diabetes and Digestive a...nstitutes of Health (NIH), announces awards to eig...ive studies of urologic chronic pelvic pain disord...rostate. The total research investment for the fiv...ion. , "The launch of this novel research effort...
    Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Nearly Half of Americans Won't Flee Without Fido 2Health News:Nearly Half of Americans Won't Flee Without Fido 3Health News:Nearly Half of Americans Won't Flee Without Fido 4Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 2Health News:Domestic AIDS Epidemic Ignored at Republican National Convention 3Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 2Health News:NIH launches unique effort to advance study of urologic chronic pelvic pain disorders 3
    ...fret or blame all those people who had been tellin...ays an important part for bone strength but is not...utrients as well. // As per a recent study which i... funded by the US government “Calcium and vitamin ...
    ... could be a significant predictor for periodontal ...researchers from University at Buffalo. Furthermor...nt of age, sex, race, ethnic background or smoking...dontal disease and obesity could be due to the und...
    ...ralian lady patient, has become the first receipen...ich depends on seaweed. She is believed to be the ...ansplant procedure, an experiment that will not ne...art was injected with about 200,000 pancreatic ce...
    ...s is a problem where people are plagued all round ... Jan Dawson suffered from it since she was three. ...oldiers marching up and down a metal spiral stairc...s still persist and it never goes away. She being ...
    Other Medicine News:Health News:Calcium in isolation no good for maintaining bone integrity 2Health News:Tinnitus: a problem which is still ambiguous 2
    (Date:9/3/2008)...irstCall/ -- Simcere,Pharmaceutical Group (NYSE: ...ded generic pharmaceuticals and manufacturer of th...known as Endostar) in China,announced the interim... request of the SFDA, Simcere initiated a Phase IV... therapeutic efficacy of Endu, a modified,version ...
    (Date:9/3/2008)... Disease Awareness Month, CHARLOTTESVILLE, Va., S...LC, a clinical-stage drug-development company comm...edical needs, announced today that it has begun,to... its lead drug,candidate trans sodium crocetinate ...inicaltrials.gov Website, is investigating TSC as ...
    (Date:9/3/2008)...onedarone) decreased the risk of,stroke by 34% in ... already adequately treated by antith...ewswire-FirstCall/ -- The results of a,post-hoc an...ented today at,the clinical trial update session o..., in Munich, Germany. Previous results from the la...
    (Date:9/3/2008)...vidence Pycnogenol(R) Lowers Joint, Pain, Symptoms...Cessation of the Extra...ing to the Center for,Disease Control (CDC), osteo...n the rise. A new study published in the August jo...(R), bark extract from the French maritime pine,tr...
    Breaking Medicine Technology:Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 2Simcere Pharmaceutical Group Announces Interim Results of Endu Phase IV Clinical Study 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent 6842 1Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent 6842 2Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent 6842 3Silence Therapeutics Receives Allowance from United States Patent and Trademark Office for its Core RNAi Patent 6842 4Sentrx Growth Continues with Four New Clients in Second Quarter 24715 1Sentrx Growth Continues with Four New Clients in Second Quarter 24715 2Sentrx Growth Continues with Four New Clients in Second Quarter 24715 3American Kidney Fund Launches Screening Program in New York City 24712 1American Kidney Fund Launches Screening Program in New York City 24712 2Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 1Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 2Healthcare Leaders Focus on Patient Centered Care at Annual Planetree Conference 24709 3
    ...7-Australian bio-discovery company Apollo,Life Sci...f its,patented needle-free vaccine technology, whi... the skin) without the need for an,injection. , Ac...ints the way,to the possibility that flu injection...ter months fast approaching, people around,Austral...
    ...NESS WIRE)--May 1, 2007 - Progenics,Pharmaceutical...sults from the first clinical trial of its investi...th the human immunodeficiency,virus (HIV), the cau...5.0 mg/kg dose of PRO 140 achieved an average maxi...of 98.5% (1.83,log10), with individual reductions ...
    Other Medicine Technology:Apollo develops needle-free topical vaccine 2Apollo develops needle-free topical vaccine 3Apollo develops needle-free topical vaccine 4Apollo develops needle-free topical vaccine 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 2Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 3Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 4Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 5Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 6Progenics Announces Positive Results in Clinical Trial of Novel HIV,Therapy 7